Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 29.41 % |
3 Month Return | + 45.28 % |
1 Year Return | + 127.68 % |
Market Stats | |
Previous Close | ₹77.00 |
Open | ₹75.46 |
Volume | 50.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹79.26Cr |
P/E Ratio | -427.78 |
PEG Ratio | 2376.54 |
Market Cap | ₹79.26 Cr |
P/B Ratio | 6.11 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Healthcare |
ROE | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹79.26 Cr | 20.21% | 0.58 | NA | NA | |
NA | ₹182.43 Cr | 1028.78% | 0.51 | NA | NA | |
NA | ₹59.28 Cr | 23.28% | 0.50 | NA | ₹34 Cr | |
BUY | ₹1,352.59 Cr | -3.57% | 0.59 | ₹41 Cr | ₹337 Cr | |
NA | ₹186.70 Cr | -1.71% | 0.71 | ₹4 Cr | ₹84 Cr |
Organisation | Aspira Pathlab & Diagnostics Ltd |
Headquarters | Mumbai |
Industry | Healthcare |
E-voting on shares | Click here to vote |
Key events for Aspira Pathlab & Diagnostics Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, Aspira Pathlab stock has moved up by 29.4%
Best in 1 Year
In the last 1 year, Aspira Pathlab has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 184.1% return, outperforming this stock by 201.3%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 81.45% of holdings in Dec 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 18.55% of holdings in Dec 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 18.55% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 81.45% | 0.00 | |
Others | 0% | 0.00 |
Aspira Pathlab & Diagnostics Ltd in the last 5 years
Lowest (-450.00x)
January 14, 2025
Today (-427.78x)
January 30, 2025
Industry (94.77x)
January 30, 2025
Highest (0.00x)
September 27, 2024
Aspira Pathlab & Diagnostics Ltd’s net profit jumped 106.94% since last year same period to ₹0.05Cr in the Q1 2024-2025. On a quarterly growth basis, Aspira Pathlab & Diagnostics Ltd has generated 110% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Aspira Pathlab & Diagnostics Ltd is currently in a Bullish trading position according to technical analysis indicators.
Aspira Pathlab & Diagnostics Ltd share price today stands at ₹75.46, Open: ₹75.46, Previous Close: ₹77, High: ₹75.51, Low: ₹75.46, 52 Week High: ₹83.93, 52 Week Low: ₹25.
Aspira Pathlab & Diagnostics Ltd is not listed on NSE
Aspira Pathlab & Diagnostics Ltd is listed on BSE
Today's traded volume of Aspira Pathlab & Diagnostics Ltd(540788) is 50.00.
Today's market capitalisation of Aspira Pathlab & Diagnostics Ltd(540788) is ₹79.26Cr.
Aspira Pathlab & Diagnostics Ltd (540788) share price is ₹75.46. It is down -10.09% from its 52 Week High price of ₹83.93
Aspira Pathlab & Diagnostics Ltd (540788) share price is ₹75.46. It is up 201.84% from its 52 Week Low price of ₹25
PE Ratio of Aspira Pathlab & Diagnostics Ltd is -427.78
PE ratio = Aspira Pathlab & Diagnostics Ltd Market price per share / Aspira Pathlab & Diagnostics Ltd Earnings per share